NCT00895245: Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy |
|
|
| Terminated | 2 | 6 | US | fosaprepitant dimeglumine, cisplatin, CACP, CDDP, CPDD, DDP, Neoplatin, palonosetron hydrochloride, Aloxi, RS 25259-197, dexamethasone, Aeroseb-Dex, Decaderm, Decadron, Decaspray, DM, DXM, Functional Living Index-Emesis Questionnaire, Emesis Diary, Radiotherapy, 3-D conformal radiotherapy or IMRT | University of Washington, National Cancer Institute (NCI) | Nausea and Vomiting, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx | 09/10 | 02/11 | | |
CADEN, NCT00953420: Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes |
|
|
| Completed | 2 | 20 | US | Docetaxel, Taxotere, Carboplatin, Paraplatin, Dexamethasone, Decadron, EBV-specific cytotoxic T lymphocytes, EBV-specific cytotoxic T lymphocytes 1 x 10e8 cells/m2 IV, G-CSF or Peg-GCSF, Filgrastim or pegylated filgrastim | Baylor College of Medicine, The Methodist Hospital Research Institute, Center for Cell and Gene Therapy, Baylor College of Medicine, M.D. Anderson Cancer Center | Nasopharyngeal Carcinoma | 06/14 | 07/15 | | |
